Inmedic Group ApS: Financial statements 2024
CVR: 40711171
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Inmedic Group ApS (CVR 40711171) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 105,637 and a net result of DKK 441,754 compared with DKK 363,969 the year before. That is a decrease of 81.2% compared with the year before. Equity in the 2024 report amounted to DKK 1,567,440. The solvency ratio was 97.8%.
- Gross Profit
- DKK 105,637
- Profit/Loss
- DKK 441,754
- Equity
- DKK 1,567,440
- Total Assets
- DKK 1,603,272
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 106 t. | 442 t. | 1.6 mio. | 0 |
| 2023 | - | 562 t. | 364 t. | 1.1 mio. | 0 |
| 2022 | - | 514 t. | 433 t. | 762 t. | 0 |
| 2021 | - | -156 t. | -166 t. | 328 t. | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Inmedic Group ApS has published its annual report for 2023. Gross profit came to DKK 562,047, and the net result was DKK 363,969.
About Inmedic Group ApS
Inmedic Group ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2019. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Nordic Cannabis Research ApS. The management consists of Henrik Lund Uth. The company is owned by DAM-ANDERSEN ApS, HEMAR ApS and Schejbel Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 102,384 and a net result of DKK 563,568 compared with DKK 441,754 the year before. Equity in the 2025 report amounted to DKK 2,131,008.